{"schema_version":"secwatch.filing_event.v1","accession":"0001384101-21-000118","form_type":"8-K","ticker":"VCYT","cik":"0001384101","company_name":"VERACYTE, INC.","filed_at":"2021-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.905218+00:00","generated_at":"2026-06-30T06:01:39.333725+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Veracyte appoints Rebecca Chambers as CFO effective July 19, 2021","bullets":["Rebecca Chambers, 43, appointed CFO effective July 19, 2021; previously CFO of Outset Medical.","Jane Alley resigns as acting CFO (same date) but remains VP, Corporate Controller and PAO.","Chambers gets $450K salary, $100K sign-on bonus, 67,000 stock options, 34,000 RSUs, and up to 13,600 performance-based RSUs.","Severance: 50% base salary for non-CIC termination; 150% plus full equity vesting for change-of-control termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001384101-21-000118","json":"https://secwatch.observer/filing/0001384101-21-000118.json","markdown":"https://secwatch.observer/filing/0001384101-21-000118.md","text":"https://secwatch.observer/filing/0001384101-21-000118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000118/0001384101-21-000118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000118/vcyt-20210712.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T06:01:39.333725+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"60c51f8cd1","claim":"Jane Alley departed as Acting Chief Financial Officer at VERACYTE, INC..","evidence_excerpt":"Jane Alley, Acting Chief Financial Officer, would be resigning from her position as Acting Chief Financial Officer, effective as of July 19, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000118/0001384101-21-000118-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigning"},{"label":"Role","value":"Acting Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"9148a0a839","claim":"Rebecca Chambers was appointed as Chief Financial Officer at VERACYTE, INC..","evidence_excerpt":"On July 12, 2021, Veracyte, Inc. (the “Company”) announced that it appointed Rebecca Chambers, 43, as Chief Financial Officer, effective as of July 19, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000118/0001384101-21-000118-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}